Business / Finance

RSS

Allscripts to market NoteSwift 2.0 for Allscripts Professional EHR

NoteSwift, Inc. and Allscripts have entered into an agreement for Allscripts to market and resell NoteSwift 2.0 for Allscripts Professional EHR. In response to customer demand, this strategic agreement may help providers reduce the time spent on creating patient documentation by more than half through the use of medical speech recognition.

19 Mar 2015

INTEGRA Biosciences announces opening of German subsidiary

Following on from the successful launch of subsidiaries in France, the UK and the USA - INTEGRA Biosciences has announced the opening in January 2015 of a new organisation based in Konstanz, Germany.

From INTEGRA Biosciences 19 Mar 2015

AbbVie signs exclusive worldwide license agreement with C2N for Alzheimer's disease therapies

AbbVie today announced that it has entered into an exclusive worldwide license agreement with C2N Diagnostics, a privately held protein diagnostic and therapeutic discovery company, to develop and commercialize a portfolio of anti-tau antibodies for the treatment of Alzheimer's Disease and other neurological disorders.

19 Mar 2015

Antech Diagnostics agrees to acquire assets of AVRL for $21 million from Abaxis

Abaxis, Inc., a medical products company manufacturing point-of-care blood analysis systems, and VCA Inc., a leading animal healthcare company in the United States and Canada, today jointly announced Antech Diagnostics, Inc., VCA's laboratory division, has agreed to acquire the assets of AVRL (Abaxis Veterinary Reference Laboratory) from Abaxis for $21 million in cash.

19 Mar 2015

Sigma-Aldrich, Roche sign distribution agreement for Biochemical Reagents products

Sigma-AldrichCorporation, a leading Life Science and Technology company, announced today it signed an exclusive global distribution agreement with Roche. The agreement pairs Roche's high-quality Biochemical Reagents product portfolio with the industry-leading eCommerce and supply chain capabilities of Sigma-Aldrich.

19 Mar 2015

ImmunoCellular, PharmaCell sign manufacturing agreement for European production of ICT-107

ImmunoCellular Therapeutics, Ltd. today announced the establishment of an agreement with PharmaCell B.V. to provide contract manufacturing services for the European production of ICT-107, a dendritic cell-based cancer immunotherapy in development as a potential treatment for glioblastoma (GBM).

19 Mar 2015

Daiichi Sankyo signs co-commercialization agreement with AstraZeneca for MOVANTIK (naloxegol)

Daiichi Sankyo, Inc. today announced a co-commercialization agreement with AstraZeneca for MOVANTIK (naloxegol) in the US, in line with the Daiichi Sankyo strategy to expand its US portfolio through strategic alliances, in addition to internal R&D and acquisitions.

19 Mar 2015

Ensocare to serve as authorized re-seller for iMPak's medication management system

An agreement was reached today between Ensocare and New Jersey-based iMPak Health to include iMPak's innovative medication management system, Kraken, as part of the Ensocare sales portfolio. Ensocare will serve as an authorized re-seller for the Kraken system, which may be sold alone or, in the future, as an integrated feature inside of Ensocare's Sync and Connect software engines.

19 Mar 2015

Janssen announces acquisition of XO1

Janssen Pharmaceuticals, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, announced today that it has acquired XO1 Limited, a privately held asset-centric virtual biopharmaceutical company founded to develop the anti-thrombin antibody ichorcumab.

19 Mar 2015

SST Group to become exclusive distributor for MPTronic's RDM solution in U.S. and Canada

SST Group, Inc., a leading provider of DICOM distribution solutions in the United States, is excited to announce its partnership with MPTronic, a leading developer of Radiation Dose Monitoring systems in Europe, Middle East and Africa.

18 Mar 2015

RMANJ acquires IVF New Jersey

Reproductive Medicine Associates of New Jersey, a world-renowned leader in the field of infertility, today announced the strategic acquisition of IVF New Jersey Fertility and Gynecology Center, one of the largest fertility centers in New Jersey.

18 Mar 2015

Columbia Laboratories' revenues increase 11% to $32.5 million in 2014

Columbia Laboratories, Inc., today announced financial results for the three- and twelve-month periods ended December 31, 2014.

18 Mar 2015

PlanSource expands U.S. presence with ClearBenefits acquisition

PlanSource, which provides the leading cloud-based health exchange and benefits engagement platform, today announced the acquisition of the ClearBenefits benefits administration business from BENU, Inc. located in San Mateo, CA.

18 Mar 2015

DigiPath, Blue Line sign preferred supplier marketing and resource-sharing agreement

DigiPath, Inc., the independent digital pathology and cannabis testing, education, and media firm, has entered into a preferred supplier marketing and resource-sharing agreement with Blue Line Protection Group.

18 Mar 2015

Gentronix signs three-year technology access deal with SIMM

UK based Gentronix Limited, the specialist genetic toxicology company, today announced it has signed a three year technology access deal with one of China's most prestigious research intensive institutes, Shanghai Institute Materia Medica, Chinese Academy of Sciences.

18 Mar 2015

Pharmalink AB acquires anti-inflammatory drug candidate from Synartro AB

Pharmalink AB, a specialty pharma company, announces that it has acquired a novel product candidate in development for treating inflammation from Synartro AB. No financial details are disclosed.

18 Mar 2015

BD announces completion of CareFusion acquisition

Becton, Dickinson and Company today announced that it completed its acquisition of CareFusion Corporation pursuant to the terms of its previously announced Agreement and Plan of Merger, dated October 5, 2014 (the "Merger Agreement").

From BD (Becton, Dickinson and Company) 17 Mar 2015

Janssen Pharmaceutical to invest $10 million in global Dementia Discovery Fund

Johnson & Johnson today announced that its Janssen Pharmaceutical Companies will invest $10 million in a new UK government-led global dementia discovery fund that will support innovative research to help find new ways to prevent and treat dementia and Alzheimer's disease.

17 Mar 2015

Kennedy Funding Financial completes $3.5 million loan for Lifestyle Real Estate I

Kennedy Funding Financial LLC has completed a $3.5 million loan for Lifestyle Real Estate I, LP, announced Gregg Wolfer, COO of the Englewood Cliffs, NJ-based direct private lender. The borrower is an affiliate of Lifestyle Healthcare Group (LHG), and the collateral is a 10.31-acre tract of vacant land in Bensalem Twp., Bucks County, PA. LHG has received approval from the township for a $185 million medical office campus.

17 Mar 2015

NantWorks, Sorrento collaborate to discover and develop novel anti-cancer immunotherapies

NantWorks, Inc. and Sorrento Therapeutics, Inc., announced today that they have entered into a binding agreement to initiate a global collaboration to discover and develop novel anti-cancer immunotherapies derived from Sorrento's proprietary G-MAB library against neoepitopes of tumor-specific antigens discovered using NantWorks' proprietary pan-omics based, precision medicine approach.

16 Mar 2015

Business / Finance

Allscripts to market NoteSwift 2.0 for Allscripts Professional EHR

INTEGRA Biosciences announces opening of German subsidiary

AbbVie signs exclusive worldwide license agreement with C2N for Alzheimer's disease therapies

Antech Diagnostics agrees to acquire assets of AVRL for $21 million from Abaxis

Sigma-Aldrich, Roche sign distribution agreement for Biochemical Reagents products

ImmunoCellular, PharmaCell sign manufacturing agreement for European production of ICT-107

Daiichi Sankyo signs co-commercialization agreement with AstraZeneca for MOVANTIK (naloxegol)

Ensocare to serve as authorized re-seller for iMPak's medication management system

Janssen announces acquisition of XO1

SST Group to become exclusive distributor for MPTronic's RDM solution in U.S. and Canada

RMANJ acquires IVF New Jersey

Columbia Laboratories' revenues increase 11% to $32.5 million in 2014

PlanSource expands U.S. presence with ClearBenefits acquisition

DigiPath, Blue Line sign preferred supplier marketing and resource-sharing agreement

Gentronix signs three-year technology access deal with SIMM

Pharmalink AB acquires anti-inflammatory drug candidate from Synartro AB

BD announces completion of CareFusion acquisition

Janssen Pharmaceutical to invest $10 million in global Dementia Discovery Fund

Kennedy Funding Financial completes $3.5 million loan for Lifestyle Real Estate I

NantWorks, Sorrento collaborate to discover and develop novel anti-cancer immunotherapies

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Latest News